BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 31208058)

  • 1. Modeling of
    Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
    Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
    Wyles SP; Hrstka SC; Reyes S; Terzic A; Olson TM; Nelson TJ
    Clin Transl Sci; 2016 Jun; 9(3):158-67. PubMed ID: 27105042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy.
    Lee J; Termglinchan V; Diecke S; Itzhaki I; Lam CK; Garg P; Lau E; Greenhaw M; Seeger T; Wu H; Zhang JZ; Chen X; Gil IP; Ameen M; Sallam K; Rhee JW; Churko JM; Chaudhary R; Chour T; Wang PJ; Snyder MP; Chang HY; Karakikes I; Wu JC
    Nature; 2019 Aug; 572(7769):335-340. PubMed ID: 31316208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.
    Wyles SP; Li X; Hrstka SC; Reyes S; Oommen S; Beraldi R; Edwards J; Terzic A; Olson TM; Nelson TJ
    Hum Mol Genet; 2016 Jan; 25(2):254-65. PubMed ID: 26604136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
    Siu CW; Lee YK; Ho JC; Lai WH; Chan YC; Ng KM; Wong LY; Au KW; Lau YM; Zhang J; Lay KW; Colman A; Tse HF
    Aging (Albany NY); 2012 Nov; 4(11):803-822. PubMed ID: 23362510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleterious assembly of the lamin A/C mutant p.S143P causes ER stress in familial dilated cardiomyopathy.
    West G; Gullmets J; Virtanen L; Li SP; Keinänen A; Shimi T; Mauermann M; Heliö T; Kaartinen M; Ollila L; Kuusisto J; Eriksson JE; Goldman RD; Herrmann H; Taimen P
    J Cell Sci; 2016 Jul; 129(14):2732-43. PubMed ID: 27235420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
    Shimoda Y; Murakoshi N; Mori H; Xu D; Tajiri K; Hemmi Y; Sato I; Noguchi M; Nakamura Y; Hayashi Y; Ieda M
    Stem Cell Res; 2022 Jul; 62():102793. PubMed ID: 35500377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An abnormal TRPV4-related cytosolic Ca
    Lu J; Lee YK; Ran X; Lai WH; Li RA; Keung W; Tse K; Tse HF; Yao X
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2964-2972. PubMed ID: 28754452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
    Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
    BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients.
    Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A
    Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
    Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
    Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
    Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.